Achieve Life Sciences, Inc. - Common Shares (ACHV)
ACHV moved a median of -0.54% 30 minutes after news, and +0.33% by the close. How ACHV actually reacts to news — the realized, point-in-time move the market made, measured across 269 labeled events over the last three years with zero look-ahead.
ACHV’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.22% | 53% | 262 |
| 30-min | -0.54% | 42% | 269 |
| 60-min | -0.49% | 43% | 269 |
| to close | +0.33% | 53% | 268 |
| Middle 50% of ACHV reactions | -2.02% to +0.99% |
|---|---|
| Median reaction (30-min) | -0.54% |
| Measured reactions | 269 |
Half of all Achieve Life Sciences, Inc. - Common Shares news events land between -2.02% and +0.99% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ACHV reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 25 | +0.44% | 68% | +1.92% |
| Rating reiterations | 24 | -0.47% | 38% | -0.07% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how ACHV ranks against every other measured name →
That’s how ACHV usually reacts — get an email when it moves on news →Email me when ACHV moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ACHV's baseline. Nothing else.
Recent ACHV events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications | Press release | GlobeNewswire | -0.13% | +3.13% | |
| Achieve Life Sciences Announces Granting of New Hire Inducement Awards | Press release | GlobeNewswire | -0.13% | +3.13% | |
| Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer | Press release | GlobeNewswire | +0.13% | -4.56% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: Oct 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.99% | |
| Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 | Press release | GlobeNewswire | -0.13% | +3.33% | |
| Achieve Life Sciences Announced Granting of New Hire Inducement Awards | Press release | GlobeNewswire | +0.24% | +3.54% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.67% | |
| Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | GlobeNewswire | +0.97% | +2.89% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.67% | -1.18% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -0.67% | -1.18% | |
| Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality | Press release | GlobeNewswire | -2.20% | -0.79% | |
| Achieve Life Sciences Announced Granting of New Hire Inducement Awards | Press release | GlobeNewswire | +0.64% | +1.91% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: Jul 02 | SEC filing · Form 8-K | SEC EDGAR | -1.41% | +2.03% | |
| Achieve Life Sciences Joins Russell 2000® Index | Press release | GlobeNewswire | +3.34% | +4.18% | |
| Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA | Press release | GlobeNewswire | +4.76% | +3.24% | |
| Form ARS ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.79% | +0.18% | |
| Form DEF 14A ACHIEVE LIFE SCIENCES, For: Jun 08 | SEC filing · Form DEF | SEC EDGAR | +1.79% | +0.18% | |
| Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors | Press release | GlobeNewswire | -1.32% | -5.09% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: May 29 | SEC filing · Form 8-K | SEC EDGAR | -1.32% | -5.09% | |
| Form PRE 14A ACHIEVE LIFE SCIENCES, For: May 29 | SEC filing · Form PRE | SEC EDGAR | -0.39% | +3.92% | |
| Form EFFECT ACHIEVE LIFE SCIENCES, | SEC filing · Form EFFECT | SEC EDGAR | +2.17% | +1.51% | |
| Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | Press release | GlobeNewswire | +0.11% | -4.20% | |
| Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | GlobeNewswire | +3.74% | +11.96% | |
| Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma | Press release | GlobeNewswire | +3.74% | +11.96% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.74% | +11.96% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +3.74% | +11.96% | |
| Form S-3 ACHIEVE LIFE SCIENCES, | SEC filing · Form S-3 | SEC EDGAR | -0.67% | +0.34% | |
| Form S-8 ACHIEVE LIFE SCIENCES, | SEC filing · Form S-8 | SEC EDGAR | -0.67% | +0.34% | |
| Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 | Press release | GlobeNewswire | -0.11% | +3.64% | |
| Form 10-K/A ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.59% | -0.23% | |
| Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors | Press release | GlobeNewswire | +7.73% | +4.68% | |
| Achieve Life Sciences Announces Up to $354 Million Private Placement | Press release | GlobeNewswire | +6.11% | +5.02% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | +2.12% | +3.03% | |
| Form S-8 ACHIEVE LIFE SCIENCES, | SEC filing · Form S-8 | SEC EDGAR | +2.12% | +3.03% | |
| Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions | Press release | GlobeNewswire | +3.86% | +14.15% | |
| Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability | Press release | GlobeNewswire | -2.48% | +2.48% | |
| Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates | Press release | GlobeNewswire | -1.64% | -20.77% | |
| Form 10-K ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.64% | -20.77% | |
| Form 8-K ACHIEVE LIFE SCIENCES, For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | -1.64% | -20.77% | |
| Form S-8 ACHIEVE LIFE SCIENCES, | SEC filing · Form S-8 | SEC EDGAR | -4.13% | -6.93% | |
| Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 | Press release | GlobeNewswire | +1.09% | +0.00% | |
| Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study | Press release | GlobeNewswire | +0.46% | +4.57% | |
| Achieve Life Sciences Announced Granting of New Hire Inducement Awards | Press release | GlobeNewswire | -1.91% | +2.87% | |
| Form EFFECT ACHIEVE LIFE SCIENCES, | SEC filing · Form EFFECT | SEC EDGAR | +2.52% | -4.13% | |
| Form S-3 ACHIEVE LIFE SCIENCES, | SEC filing · Form S-3 | SEC EDGAR | -2.19% | -7.29% | |
| Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer | Press release | GlobeNewswire | -2.25% | +1.98% | |
| Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week | Press release | PR Newswire | +3.54% | +2.36% | |
| Achieve Life Sciences Announced Granting of New Hire Inducement Awards | Press release | GlobeNewswire | +1.73% | +1.08% | |
| Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program | Press release | GlobeNewswire | -0.71% | -4.43% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.71% | -4.43% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ACHV section they belong to.
Where else ACHV is measured.
ACHV earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | 271 | -0.56% | 41% |
| PRESBIA PLC ORDINARY SHARES (LENS) | 270 | 0.00% | 42% |
| CorMedix Inc. (CRMD) | 269 | -0.42% | 39% |
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Achieve Life Sciences, Inc. - Common Shares's median reaction calculated?
Every labeled ACHV news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 269 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 42% of ACHV's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ACHV's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.